Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,000
Closed -$95.2K 162
2025
Q3
$95.2K Buy
+1,000
New +$91.9K 0.01% 103
2023
Q1
Sell
-3,300
Closed -$256K 107
2022
Q4
$256K Sell
3,300
-11,800
-78% -$956K 0.03% 93
2022
Q3
$1.22M Buy
15,100
+100
+0.7% +$8.99K 0.1% 166
2022
Q2
$1.35M Sell
15,000
-37,200
-71% -$3.77M 0.1% 148
2022
Q1
$5.79M Buy
+52,200
New +$5.51M 0.22% 97
2021
Q4
Sell
-22,600
Closed -$2.83M 189
2021
Q3
$2.83M Buy
22,600
+16,200
+253% +$2.1M 0.18% 73
2021
Q2
$794K Buy
6,400
+2,600
+68% +$326K 0.08% 133
2021
Q1
$449K Buy
3,800
+1,600
+73% +$188K 0.04% 58
2020
Q4
$259K Buy
+2,200
New +$242K 0.02% 46

Other funds holding MDT

QVR's MDT Position: Q4 2025 in Review

QVR sold out of Medtronic (MDT) in Q4 2025, closing a stake of 1,681 shares — an estimated $160K sold.

QVR first reported a position in MDT in Q4 2020 and held it in 8 quarters. The position peaked at $457K in Q3 2022. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • QVR reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • QVR sold 1,681 Medtronic shares in Q4 2025, an estimated $160K.
  • QVR first reported a position in Medtronic in Q4 2020 and held it in 8 quarters.
  • QVR's Medtronic position peaked at $457K in Q3 2022.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on QVR's 13F filing for Q4 2025, filed 28 Jan 2026.